3 Tech Stocks To Buy For The Bounce (MSFT, TXN)
The Nasdaq-100 index and big tech stocks have been battered and bruised since the presidential election, losing ground in a major rotation out of traditional growth instruments and into market…
Barristers.ng
The Nasdaq-100 index and big tech stocks have been battered and bruised since the presidential election, losing ground in a major rotation out of traditional growth instruments and into market…
Ric Dillon is a well-known investor who founded the successful hedge fund Diamond Hill Capital Management. Created in 2000, the $16.18 billion fund uses a fundamental strategy which focuses on…
I was intrigued by a comment made by Anne Boden, founder of Starling Bank, on a panel I chaired the other day. Anne used to work for ABN Amro, AIB…
Image source: iStock/Thinkstock. It’s hard to imagine that Bank of America‘s (NYSE:BAC) stock could climb even higher from here, seeing as it rose 28% in November, but there’s one thing…
Electric-car maker Tesla Motors‘ (NASDAQ:TSLA) upcoming $35,000 Model 3 is very important, if not critical, for the company’s success. Pairing Tesla’s massive under-construction Gigafactory and plans for production capacity to…
With the election of Donald Trump, the big question for gold investors is whether the uptrend that started earlier in the year is still intact, or the steep precious-metals decline…
Image source: Big Lots. Discount retailer Big Lots (NYSE:BIG) on Friday posted a second straight quarter of declining same-store sales, notching flat comps in the third quarter. That did meet…
Smith & Wesson stock plunged after President-elect Donald Trump beat Hillary Clinton. It’s falling again on Friday, after the stock “beat” earnings. SWHC Total Return Price data by YCharts. What…
Image source: PACCAR. What happened Shares of medium- and heavy-duty truck manufacturer PACCAR Inc (NASDAQ:PCAR) jumped 13.2% in November, continuing a run from earlier this year that has moved the…
Many biotech stocks posted underwhelming performances in 2016. None, however, lost as badly as Novavax (NASDAQ:NVAX), Celldex Therapeutics (NASDAQ:CLDX), and Seres Therapeutics (NASDAQ:MCRB). Here are the negatives that made them…
This video cannot play here.
Download it insteadLog in to comment.